Close Menu

Essure Lawsuit Update Essure will be taken off the market as of December 31, 2018 due to decline in sales, announced Bayer. The controversial coil implants were linked to pain and suffering in thousands of women who have filed lawsuits against the corporation. View the ABC News Video Update: ABC News Essure Report. This follows thousands of lawsuits and the FDA restrictions placed on the controversial metal contraceptive in April 2018. The FDA issued warnings that must be acknowledged by every women considering the metal birth control device before implantation in the Fallopian tubes. The warning included reported adverse events, including, perforation of the uterus and/or fallopian tubes, migration  into the abdominal or pelvic cavity, persistent pain, and suspected allergic or hypersensitivity reactions. If the device needs to be removed to address such an adverse event, a surgical procedure will be required. Read the FDA warnings here: Essure Permanent Birth Control > FDA Activities: Essure.   Lawsuits further allege that the Essure birth control devices implanted in the fallopian tubes can migrate from the tubes, perforate organs, fracture into pieces, or corrode and cause pain and suffering. The women allege that the Bayer Corporation has known of Essure’s long history of adverse events, manipulated their reports and presented false and misleading information. Therefore, the plaintiffs were not fully informed of the risks of Essure and demand justice for past and future general, economic and special damages, medical expenses, punitive and exemplary damages, and other relief. CNN covered the story of the death of a baby after Essure was implanted in the mother to prevent conception. See the CNN video: FDA mandates new warnings, new data for Essure contraceptive device.  Over 5,000 women filed grievances with the FDA between November 2002 and May 2015, complaining of severe pain and bleeding, perforation, unintended pregnancies, miscarriages, stillbirths after an Essure coil was implanted in the Fallopian tubes. How Does Essure Prevent Pregnancy? During the Essure implantation procedure, metal coils are inserted through the vagina into the uterus and lodged in each fallopian tube. Over many months, scar tissue forms around the implants and prevents any sperm from reaching the eggs. If the egg is not fertilized by the sperm, no pregnancy occurs. Three months after implantation, an Essure Confirmation Test will verify whether or not the procedure was successful.  One test is the TVU – transvaginal ultrasound – to examine whether scar tissue has blocked the Fallopian tubes. Another test is a modified HCG, which involves the instillation of  contrast dye into the uterus and tubes to verify that the Fallopian tubes were successfully blocked. FDA Black Box Warning Added An earlier black box warning label for Essure to call attention to serious or life-threatening risks was added in 2016. Approved by the FDA in 2002, Essure, manufactured by Bayer and composed of metallic coils and polyester fibers, is a permanent form of birth control in which a coil is non-surgically placed into a woman’s fallopian tubes.  When implanted, the fibers and coils provoke inflammation and scar tissue which block entrance to the sperm reaching the egg. Essure has been removed from the market in other countries, but is still being implanted in U.S. women. Essure has been linked to other multiple dangerous side effects including: Hemorrhage Birth defects caused by nickel poisoning Ectopic pregnancy Premature birth due to membranes ruptured by loose coils Unintended pregnancy Miscarriage Migration of the device Malposition of the device Fracture or breakage of the device Incompatibility from nickel allergies Timeline of Serious Adverse Events 2002 to 2015: FDA receives close to 10,000 complaints from doctors and women alleging serious side effects of Essure, including 11 deaths, five for fetal deaths after Essure was implanted. June 2015: FDA noted the number of adverse event reports, along with short- and long-term risks, as part of its review of potential Essure problems. September 2015: FDA’s OB-Gyn Devices Panel holds a public meeting to discuss risks and benefits of Essure.  These included potential side effects and injuries from Essure such as ongoing pain, organ perforation, allergic reactions and device migration. February 2016: FDA requires Bayer to conduct a clinical study on the safety and efficacy of Essure. October 2016: FDA requires Bayer to add a serious black box warning to Essure labelling. October 2016: Judge Winifred Y. Smith of Alameda County Superior Court in California orders that all California Essure cases coordinated for pretrial purposes before her in Alameda County, California. Essure Timeline 1998 to 2001: Conceptus, Inc., now a subsidiary of Bayer, conducted Essure testing from 2002: Essure approved to be placed on the medical device market. 2013: Bayer AG buys Conceptus, Inc. as a subsidiary of its Germany-based chemical and pharmaceutical company. 2017: Bayer halts sales of Essure outside of the U.S. Over 3700 women have filed claims and lawsuits are consolidated in Pennsylvania before Judge John R. Padova and in California before Judge Winifred Y. Smith.  To date, there has been no mass settlement of Essure cases. Free Medical Legal Consultation If you or a loved one has or have had Essure birth control implanted and experienced serious life-threatening complications, Contact Us before your time runs out to  file a claim. We look forward to helping you in your potential claim for compensation.

Facebook Twitter LinkedIn Google Plus